LIG1 is a novel marker for bladder cancer prognosis: evidence based on experimental studies, machine learning and single-cell sequencing
Our research demonstrates that LIG1 plays a crucial role in promoting bladder cancer malignant progression by heightening proliferation, invasion, EMT, and other key functions, thereby serving as a potential risk biomarker.
Authors
- Yibo He (ORCID: https://orcid.org/0000-0003-3777-9516)
- Tong Shen (ORCID: https://orcid.org/0000-0002-7650-3275)
- Lu Han (ORCID: https://orcid.org/0000-0003-4688-0907)
- Ming Tong (ORCID: https://orcid.org/0009-0002-7302-652X)
- Shiliang Chen (ORCID: https://orcid.org/0000-0001-7079-3307)
- Yanyang Jin
- Yang Zhang (ORCID: https://orcid.org/0000-0002-8209-819X)
- Kun Feng
- Ding-ming Song
- Wen-fei Luo
Institutions
- Zhejiang Chinese Medical University (CN)
- Guiyang Medical University (CN)
- Kunming Medical University (CN)
- Fuwai Yunnan Cardiovascular Hospital (CN)
- Affiliated Hospital of Guizhou Medical University (CN)
- Jinzhou Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-08-21
- DOI
- https://doi.org/10.3389/fimmu.2024.1419126
- Citations
- 9
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 5.15